TDAC Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: April 02, 2026
Report Source: 2025 Annual Report
Translational Development Acquisition Corp. Stock Analysis TDAC
Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2024-12-23. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm has neither engaged in any operations nor generated any revenues.
Read More Translational Development Acquisition Corp (TDAC) Chart
Key Statistics of Translational Development Acquisition Corp (TDAC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$10.64Volume
29.09KP/E Ratio (TTM)
36.6052 Week Range
Market Cap
233.10MAvg. Volume
22.07KDividend Yield
-Financial Metrics & Statements of Translational Development Acquisition Corp (TDAC)
FAQ's for Translational Development Acquisition Corp (TDAC)
- According to Musaffa’s Shariah screening methodology, Translational Development Acquisition Corp (TDAC) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.